Evidence map›Paper›PMID 34856803›Full record

ArticleMolecular pharmaceutics2022

Solid-State Study of the Structure, Dynamics, and Thermal Processes of Safinamide Mesylate─A New Generation Drug for the Treatment of Neurodegenerative Diseases.

Tomasz Pawlak, Marcin Oszajca, Małgorzata Szczesio, Marek J Potrzebowski

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 8 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Tomasz PawlakCentre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, Poland.ORCID 0000-0002-0350-6395
Marcin OszajcaFaculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Krakow, Poland.
Małgorzata SzczesioInstitute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Żeromskiego 116, 90-924 Lodz, Poland.
Marek J PotrzebowskiCentre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, Poland.ORCID 0000-0001-5672-0638
Centrum Badań Molekularnych i Makromolekularnych Polskiej Akademii Nauk · PLJagiellonian University · PLLodz University of Technology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Safinamide mesylate (

Indexed as

AlanineBenzylaminesCalorimetry, Differential ScanningCrystallography, X-RayHumansMagnetic Resonance SpectroscopyMesylatesMolecular StructureNeurodegenerative DiseasesNeuroprotective AgentsThermogravimetryX-Ray DiffractionAlanineBenzylaminesMesylatesNeuroprotective AgentssafinamideAPIDFT-Ddisorder structuresGIPAWmolecular dynamicsParkinson diseasePhase transitionquantum mechanics calculationsvery-fast MAS NMRXadago

Identifiers

PMID34856803
PMCPMC8728732
OpenAlexW3214786562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.